Literature DB >> 15309262

[Palliative surgery in squamous cell carcinoma of the anterior floor of the mouth].

G Bachmann1, A Hess, O Guntinas-Lichius, M Jungehülsing.   

Abstract

A 62 year old patient presented with a bleeding, incurable squamous cell carcinoma of the anterior floor of the mouth. A curative concept was not possible. After four palliative surgical procedures, a definitive and a palliative radiation therapy and a palliative chemotherapy, the patient remained free of tumor in the head and neck region for 2 years after the initial treatment. Using a combination of palliative procedures, it is possible not only to achieve a full local remission but also to provide a high quality of life.

Entities:  

Mesh:

Year:  2004        PMID: 15309262     DOI: 10.1007/s00106-003-0936-5

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  6 in total

1.  A comparison of radiotherapy or radiochemotherapy with symptomatic treatment alone in patients with advanced head and neck carcinomas.

Authors:  A L Carvalho; J V Salvajoli; L P Kowalski
Journal:  Eur Arch Otorhinolaryngol       Date:  2000       Impact factor: 2.503

2.  [Therapeutic and palliative lymph drainage in therapy of edema in the face and neck].

Authors:  H Einfeldt; M Henkel; T Schmidt-Auffurth; G Lange
Journal:  HNO       Date:  1986-09       Impact factor: 1.284

3.  Prognostic significance of the distribution of neck node metastasis from oral carcinoma.

Authors:  L P Kowalski; R Bagietto; J R Lara; R L Santos; J F Silva; J Magrin
Journal:  Head Neck       Date:  2000-05       Impact factor: 3.147

Review 4.  [Pain therapy in patients with incurable tumors of the head and neck].

Authors:  H Luckhaupt
Journal:  HNO       Date:  1989-11       Impact factor: 1.284

5.  [Palliative antineoplastic chemotherapy of patients with head and neck tumors].

Authors:  D Kleemann; V Hingst; B Kramp
Journal:  HNO       Date:  1994-05       Impact factor: 1.284

Review 6.  [The incurable tumor patient].

Authors:  H Bier
Journal:  HNO       Date:  1994-06       Impact factor: 1.284

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.